Today, Beida Pharmaceutical (300558) hit a new low of 60 days, closing at 62.3 yuan. According to the 2021 annual report fund heavy stock data, there are 32 funds that are heavily positioned in this stock, of which the fund with the largest number of holdings is Penghua Ingenuity Select Hybrid A. The current scale of Penghua Ingenious Select Hybrid A is 11.705 billion yuan, and the latest net value is 0.8544 (January 27), down 1.4% from the previous day and 29.23% in the past year.
The fund's current manager is Wang Zonghe. Wang Zonghe's incumbent public funds include: Penghua Consumer Preferred Blend, which has a management period of 313.0% from December 28, 2010 to the present; Penghua Pension Industry Stock, which has been managed from December 2, 2014 to present, with a yield of 247.5%; Penghua China 50 Hybrid, with a management period of 110.59% from July 29, 2017 to present; Penghua Industry Selection, which has been managed from May 9, 2018 to present, The yield for the period was 97.24%.
The top ten funds of the heavy position of Beida Pharmaceutical can be found in the following table:
According to the third quarter report of Beida Pharmaceutical in 2021, the company's main revenue was 1.724 billion yuan, up 14.37% year-on-year; the net profit attributable to the mother was 347 million yuan, down 32.5% year-on-year; the deduction of non-net profit was 326 million yuan, up 21.09% year-on-year; among them, in the third quarter of 2021, the company's single-quarter main revenue was 569 million yuan, up 2.42% year-on-year; the single-quarter net profit attributable to the mother was 132 million yuan, down 64.39% year-on-year. In the single quarter, the non-net profit was 129 million yuan, up 0.46% year-on-year; the debt ratio was 20.4%, the investment income was 11.2422 million yuan, the financial expense was -1.1744 million yuan, and the gross profit margin was 92.78%. A total of 9 institutions have given ratings to the stock in the last 90 days, with 5 buy ratings and 4 overweight ratings.
The above content is compiled by Securities Star based on public information, if you have any questions, please contact us.